Please assess the completion status of the following clinical trial:

Trial Title: Vasopressin, Epinephrine, and Steroids for Cardiac Arrest

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients with refractory inhospital cardiac arrest, defined as epinephrine requirement for ventricular fibrillation/tachycardia or asystole/pulseless electrical activity according to guidelines for resuscitation 2005 (5).~Exclusion Criteria:~* Age \< 18 years~* Terminal illness or do-not resuscitate status~* Cardiac arrest due to exsanguination~* Cardiac arrest before hospital admission~* Pre-arrest treatment with intravenous corticosteroids~* Previous enrollment in or exclusion from the current study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Study Group (Type: EXPERIMENTAL): Patients with refractory, inhospital cardiac arrest, i.e., with asystole, pulseless electrical activity, or ventricular fibrillation/pulseless ventricular tachycardia not responsive to two attempts at defibrillation.
- Control Group (Type: PLACEBO_COMPARATOR): Patients with refractory, inhospital cardiac arrest, i.e., with asystole, pulseless electrical activity, or ventricular fibrillation/pulseless ventricular tachycardia not responsive to two attempts at defibrillation.

Based on this trial design, predict the completion outcome and termination type (if applicable).